Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.05+0.03 (+3.43%)
Close on Nov 18, 2026Market cap $178.87MP/E –Yield –
Cabaletta Bio gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Cabaletta Bio
Cabaletta Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?